General anaesthetics are often used in patients who are under oxidative stress due to a critical illness or surgical trauma. Some anaesthetics may worsen oxidative stress and some may act as antioxidants. The aim of this study was to evaluate liver, brain, kidney, and lung tissue oxidative stress in rats exposed to desfl urane and sevofl urane and in unexposed rats. The animals were divided in three groups: control (received only air); sevofl urane (8 %), and desfl urane (4 %). After four hours of exposure, we evaluated the levels of malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), Cu, and Zn. Exposure to either of the anaesthetics signifi cantly increased lung MDA levels compared to control (Mann-Whitney U test; P<0.05), probably because it is the tissue directly exposed to anaesthetic gases. Oxidative stress and antioxidant activity in other tissues varied between the desfl urane and sevofl urane groups. Our results suggest that anaesthesiologist should not only be aware of the oxidative or antioxidative potential of anaesthetics they use, but should also base their choices on organs which are the most affected by their oxidative action.
Free radicals are products of normal aerobic metabolism (1) . If free radical production exceeds antioxidant cell activity, this is defi ned as oxidative stress, which impairs cell membrane, damages DNA, and contributes to all infl ammatory diseases (2) .
Volatile anaesthetics cause an ischemiareperfusion (I/R) injury, which is a complex phenomenon resulting in greater production of reactive oxygen species (ROS). Eroglu et al. (3) have clearly demonstrated increase in infl ammatory mediators, I/R injury, and ROS in generalised infl ammatory reactions involving the production of leukocytes. Airway infl ammation appears to play a central role in the development of lung diseases such as asthma and chronic obstructive pulmonary disease, and Rükgauer et al. (4) demonstrated increased oxidative stress in the blood of these patients (4) .
Malondialdehyde (MDA) is an end-product of the degradation of polyunsaturated lipids by ROS (2) and is used as a biomarker of oxidative stress. On the other hand, the most common markers of cell antioxidant activity are the enzymes superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px). In addition trace elements such as Cu and Zn contribute to antioxidant enzymatic activity (5) .
Patients with an imbalance between ROS production and antioxidant activity due to surgical trauma are a specifi c population at risk. Therefore, when these patients are to be anaesthetised, it is important to select an anaesthetic which will burden their antioxidant defences the least.
S e v o f l u r a n e ( 2 , 2 , 2 -t r i f l u o r o -1 -[trifluoromethyl]ethyl fluoromethyl ether) and desflurane (2,2,2-trifluoro-1-fluoroethyldifluoromethyl ether) are very common volatile anaesthetics used for general anaesthesia. Desfl urane acts the most rapidly among volatile anaesthetics due to its low solubility in blood (6) , which is related to its lowest blood-gas partition coefficient (7) . In addition, it metabolises far less to F -compounds than sevofl urane (8) . Ideally, a volatile anaesthetic should provide smooth and reliable induction and maintenance of general anaesthesia with minimal effects on other organ systems.
The purpose of our study was to investigate the levels of oxidative stress induced by sevofl urane and desfl urane in rats using MDA as a marker of oxidative stress and enzymes SOD and GSH-Px (and their cofactors Cu and Zn) as markers of antioxidative activity. We also tried to evaluate tissue-specifi c variations between rat liver, kidney, brain, and lung.
MATERIALS AND METHODS
The study protocol was approved by the Animal Care and Utilization Committee of the Gulhane Military Medical Academy (GMMA) School of Medicine, Ankara, Turkey.
Animals
The study included 21 male Wistar rats (300 g to 365 g body weight) obtained from the GMMA Animal Research Facility. The rats were housed in cages under standard hygienic conditions, with light and dark cycles exchanging every 12 h. They received standard rat feed and had free access to water.
Experimental design
The rats were randomised into three groups of seven: unexposed control, sevofl urane, and desfl urane group. The animals were placed in a vented seven-litre inhalation chamber. Vented chambers provide optimal temperature, humidity, and inhaled gas composition. The chamber was preheated to maintain animal body temperature. After closing the lid, the rats were exposed to 3.5 % to 4 % sevofl urane or 7 % to 8 % desfl urane vaporised at a continuous oxygen fl ow of 3 L min -1 until they lost the righting refl ex. Constant vacuum above the chamber was used to capture excess gas and when the animals lost the righting refl ex, sevofl urane or desfl urane concentrations were lowered to allow the animals to breathe spontaneously. Anaesthesia continued for four hours during which we monitored animal movement and breathing. At the end of the anaesthesia, the rats were decapitated, and their brains, lungs, livers, and kidneys collected and fi xed with formol. Tissue samples were minced and homogenised in a cold potassium chloride (KCl) solution (1.15 %) and centrifuged at 4,400 rpm and +4 °C for 15 minutes. The supernatants were then used to analyse MDA, SOD, GSH-Px, Cu, and Zn, as described below.
Biochemical analysis of oxidant/antioxidant parameters
All chemicals and reagents were purchased from Sigma-Aldrich (St. Luis, USA) and Merck (Darmstadt, Germany). Cu,Zn-SOD, GSH-Px, and MDA were m e a s u r e d u s i n g a S h i m a d z u U V-2 1 0 0 S spectrophotometer (Kyoto, Japan).
Cu, Zn-SOD activities in supernatant were measured using a method described earlier (9, 10) . GSH-Px activities in supernatant were measured using a method described earlier (10) . Briefl y, we prepared a reaction mixture containing 1 mmol L -1 Na 2 EDTA, 2 mmol L -1 reduced glutathione, 0.2 mmol L -1 NADPH, 4 mmol L -1 sodium azide, and 1000 U glutathione reductase in 50 mmol L -1 TRIS buffer (pH 7.6). Fifty microlitres of the supernatant and 950 μL of the reaction mixture were mixed and incubated at 37 °C for 5 min. The reaction was initiated by adding 8.8 mmol L -1 hydrogen peroxide and a decrease in absorbance was recorded at 340 nm for 3 min.
Lipid peroxidation was determined by measuring MDA, using the method described by Jain (10) . Tetramethoxy propane solution was used as standard. This assay is based on the formation of red adduct in acidic medium between thiobarbituric acid and MDA; the product of lipid peroxidation was measured at 532 nm.
For (11) . The flame was an airacetylene mixture. The calibration curve interval for Cu was (2 to 6) μg mL -1 and for Zn (0.5 to 1.5) μg mL -1 .
Statistical analysis
For statistical analysis we used SPSS statistics software (version 13.0). Data were expressed as medians and ranges. The differences between the groups were compared using the Mann-Whitney U test. A P value of less than 0.05 was considered statistically signifi cant.
RESULTS
All animals completed the experiment, that is, all survived until sacrifi ce.
MDA concentrations
Compared to controls, MDA signifi cantly dropped in the sevofl urane group liver, kidney, and brain and in the desflurane group liver. However, they signifi cantly increased in the lungs of both anaestheticexposed groups. MDA in the desfl urane group was slightly higher than in the sevofl urane group in the liver and lung, but the differences were not signifi cant (Table 1) .
SOD and GSH-Px concentrations
The only signifi cant differences from control were higher brain and lower liver SOD in the desfl urane group. The sevofl urane group showed no signifi cant differences in SOD concentrations from control ( Table  2) . As for GSH-Px, only the sevofl urane group kidney tissue showed signifi cantly lower levels, but even these were within the control range. There were no other signifi cant changes in either group (Table 3) .
Zn and Cu levels
Zinc was significantly higher in the lung and kidney tissues of the desfl urane group and only in the lung tissue of the sevofl urane group (Table 4 ). The only signifi cant change in Cu levels was a drop in the lung tissue of the desfl urane group (Table 5) .
DISCUSSION
Oxidative stress occurs in many human diseases and signifi cantly contributes to their development (12) . The protective action of drugs against oxidative stress (20) found that propofol lowered oxidative stress, especially in rat brain. In a study on rats similar to ours, Abdelmajeed (21) found that intravenous diazepam increased oxidative damage to the rat liver, kidney, and heart, which was accompanied by increased nitric oxide (NO) levels.
Findings from animal studies on volatile anaesthetics and tissue oxidative stress are limited (22) . Awad et al. (23) showed that halothane caused free radical formation and impaired rat liver antioxidant defences in vivo. Sato et al. (25) found that sevofl urane also had the potential to cause lipid peroxidation in vivo and in vitro. Similarly, SOD and GSH-Px levels in our study showed weaker antioxidative potential of sevofl urane and desfl urane in rat liver and kidney, respectively.
Kudo et al. (24) studied antioxidant activity in rats with ischaemic brain injury treated with isofl urane, sevofl urane, and halothane. These volatile anaesthetics provided no direct protection against oxidative stress. This is similar to our fi nding that sevofl urane did not increase SOD and GSH-Px levels, and therefore provided no antioxidative protection of rat brain.
In swine lungs, desfl urane seemed to induce local and systemic oxidative stress, whereas sevofl urane showed antioxidative properties (26) . This is not consistent with our results, perhaps due to a different experimental design, as we did our research on rats and we did not mechanically ventilate them as Allaochiche et al. (26) did with swine. Our experimental design, which included controlled breathing environment and a relatively long time of exposure (4 hours), aimed to underline the relation between volatile anaesthetics and oxidative stress. What we have found out is that the lungs take the most of oxidative damage, being the first tissue exposed anaesthetic gas.
Our findings show that both sevoflurane and desfl urane caused an increase in MDA levels only in the lung, while in other tissues they barely altered the activity of antioxidative enzymes. This suggests that anaesthesiologist should not only be aware of the oxidative or antioxidative potential of anaesthetics they use, but should also base their choices on organs which are the most affected by their oxidative action.
